SurePure, Inc. (SURP) a global leader in liquid photopurification, today announced that it has sold its unique processing technology to Soda King (www.sodaking.co.za), a leading South African beverage producer. SurePure’s announcement follows its sale on February 2014 of its patented photopurification technology to a French flavor house.
Soda King has bought the technology to help preserve its flavors for … Read more
Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that William M. Burns, former Chief Executive Officer of Roche Pharmaceuticals, has been appointed a non-executive Director of the Mesoblast Board, effective immediately.
Mr Burns was the CEO of the pharmaceutical division of Swiss global healthcare company F.Hoffman La Roche (Roche) from 2005-2009, and a non-executive member of the Roche Board … Read more
NeoStem, Inc. (NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy industry, announced today that it has entered into a sponsored research collaboration with Massachusetts Eye and Ear/Schepens Eye Research Institute, an affiliate of Harvard Medical School.
In this collaboration, NeoStem will sponsor research in the laboratory of principal investigator Michael Young, Ph.D., Director of the Ocular Regenerative Medicine Institute … Read more
Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN:US74154B2034) (“Prima,” “the Company”) is pleased to advise that it has received approximately $1.6 million in cash rebate from the Australian federal government’s R&D tax incentive program. The cash rebate was provided essentially in respect of expenditure incurred on eligible Australian R&D activities conducted on the CVac clinical trials during the 2013 financial year.
About Prima BioMed
Prima … Read more
Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima,” “the Company”) will present at the 2nd Annual Regen Med Investor Day to be held Wednesday, March 26, 2014 in New York City.
Organized by the Alliance for Regenerative Medicine (ARM) in partnership with leading financial firms Maxim Group and Piper Jaffray, this one-day investor conference focuses exclusively on the regenerative medicine and advanced therapies sector. … Read more
GeoVax Labs, Inc. (OTCQB: GOVX), an Atlanta-based biotechnology company developing innovative, patented HIV/AIDS vaccines, today announced its financial results for the year ended December 31, 2013 and provided the following corporate update.
Therapeutic HIV Vaccine
In January of this year, GeoVax announced preliminary top-line results for a Phase 1 clinical trial (GV-TH-01) investigating the therapeutic use of its unadjuvanted DNA/MVA vaccine (GOVX-B11) in … Read more
NXT-ID, Inc., (OTCQB: NXTD) a biometrics company focused on the growing m-commerce market, announces it will be presenting at the Defense and Security Conference, “Game Changing Technologies,” to be held in New York on March 11th at The New York Hilton Midtown. The live conference will also be featured on a streaming live news and syndication platform to global media and industry followers.
The … Read more
Targeted Medical Pharma, Inc. (TRGM), announced today the launch of a new e-prescribing platform for the medical food,Theramine. The secure online e-prescribing portal is available to healthcare providers in the United States, interested in a clinically validated, peer reviewed, non-pharmacologic alternative to narcotic and NSAID pain medications for patients suffering from pain syndromes.
Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Thursday, March 6, 2014 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to provide a corporate update and report 2013 year-end financial results.
Conference Call and Webcast Information
A live webcast of the call can be … Read more